📰 Bivalent News
Page 14 - Bivalent News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bivalent. Real-time updates on events, politics, business and more.
November 20, 2022
Starting Monday, people who receive an updated COVID-19 vaccine will be offered free tickets to traditional palaces as an incentive offered by the government to individuals getting a booster shot ahead of a possible surge in infections this winter.
November 18, 2022
One month after a 30-µg booster dose of the Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine, neutralizing antibody titers against emerging Omicron sublineages increased 3.2- to 4.8-fold compared to
November 18, 2022
Pfizer and BioNTech said Friday their latest Omicron BA.4/BA.5-adapted bivalent COVID-19 booster vaccine also shows effectiveness against new subvariants of the virus. The companies said in a... | November 18, 2022
November 10, 2022
NEW YORK and MAINZ, GERMANY, November 10, 2022 - Pfizer Inc.(Nasdaq: BNTX) today announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY Original/Omicron BA.4/BA.5
November 4, 2022
Bivalent booster elicited approximately 4-fold higher neutralizing antibody titers against Omicron BA.4/BA.5 sublineages compared to the original COVID-19 vaccine in individuals older than 55 years
November 4, 2022
NEW YORK CITY (dpa-AFX) - Drug major Pfizer Inc. (PFE) and German partner BioNTech SE (BNTX) announced Friday updated data from a Phase 2/3 clinical trial for Omicron BA.4/BA.5-adapted bivalent
November 4, 2022
MRNA-1273.222 targets BA.4/BA.5 Omicron subvariants and follows the approval of mRNA-1273.214 (SPIKEVAX Bivalent) in Canada, which targets the Omicron BA.1 subvariantCAMBRIDGE, MA / ACCESSWIRE / November
November 2, 2022
Dr Jane Rudy EXPOSES The Truth About DEADLY Bivalent Boosters: DR JANE RUDY EXPOSES THE TRUTH ABOUT DEADLY BIVALENT BOOSTERS: WATCH
November 1, 2022
NEW YORK CITY (dpa-AFX) - Drug major Pfizer Inc. (PFE) announced Tuesday positive top-line data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus or RSV
November 1, 2022
THE STAR – Malaysia will receive an updated form of COVID-19 vaccine manufactured by Pfizer-BioNTech this month, said Health Minister Khairy Jamaluddin. “The original vaccine is effective against Omicron and the XBB (sub-variant). However, I would like to inform you that Malaysia has placed orders for the bivalent vaccine from Pfizer,” he said at a […]